Cargando…
VA-Wide, Multicenter Verification Study of the Cepheid Xpert SARS-CoV-2 Assay
Early in the Severe Acute Respiratory Syndrome Coronavirus 2 pandemic, there was a progressive increase in diagnostic demands that developed within a relatively short period of time. On February 4, 2020, the Secretary of Health and Human Services issued the Emergency Use Authorization for in vitro d...
Autores principales: | Obeidat, Mohammad, Frank, Amy R., Icardi, Michael S., Klutts, J. Stacey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107920/ https://www.ncbi.nlm.nih.gov/pubmed/33997277 http://dx.doi.org/10.1177/23742895211011911 |
Ejemplares similares
-
Recommendations for sample pooling on the Cepheid GeneXpert(®) system using the Cepheid Xpert(®) Xpress SARS-CoV-2 assay
por: Becker, Michael G., et al.
Publicado: (2020) -
Multicenter Evaluation of the Cepheid Xpert(®) HBV Viral Load Test
por: Marcuccilli, Fabbio, et al.
Publicado: (2021) -
Multicenter Evaluation of the Cepheid Xpert GBS LB XC Test
por: Thwe, Phyu M., et al.
Publicado: (2022) -
The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic
por: Crawford, James M., et al.
Publicado: (2021) -
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
por: Loeffelholz, Michael J., et al.
Publicado: (2020)